Lopinavir
Drug Details
- Generic Name
- Lopinavir
- Brand Names
- N/A
- Application Number
- Sponsor
- Hetero Labs Limited
- NDC Codes
- 6
- Dosage Forms
- POWDER
- Routes
- N/A
- Active Ingredients
- LOPINAVIR
Indications and Usage
1 INDICATIONS AND USAGE Lopinavir and ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV- 1 infection in adults and pediatric patients 14 days and older. Limitations of Use: Genotypic or phenotypic testing and/or treatment history should guide the use of lopinavir and ritonavir. The number of baseline lopinavir resistance-associated substitutions affects the virologic response to lopinavir and ritonavir [ see Microbiology (12.4) ] . Lopinavir and ritonavir is an HIV-1 protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients (14 days and older). ( 1 )